Agenus: Novel Drugs That Just Are Not Novel
Seeking Alpha,
Follow Summary Agenus is a small biotech company focused on developing cancer treatments, with a history of poor stock…
Follow Summary Agenus is a small biotech company focused on developing cancer treatments, with a history of poor stock…
This Reading Room is a collaboration between MedPage Today® and: A novel combination of the anti-programmed death-1 (PD-1…
The immuno-oncology company Agenus has made the decision to withdraw its biologic license application for the use of the PD-1…
GlobeNewswire 2021-10-22 Company voluntarily withdraws BLA at FDA’s recommendation following full approval of pembrolizumab…